EMILY LEE: Open Payments
NPI 1760727655 · ELDERSBURG, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$890 in 42 payments from 17 companies in 2025. Trend: 2023 $1,078 · 2024 $802 · 2025 $890
Food & beverage: $890
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $224 |
| Corcept Therapeutics | 10 | $178 |
| ABBVIE INC. | 4 | $86 |
| Dexcom, Inc. | 1 | $70 |
| Bausch Health US, LLC | 2 | $47 |
| PFIZER INC. | 2 | $45 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Amgen Inc. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
Products named: Korlym, Rybelsus, DEXCOM G7 GSS (161), Ozempic, WELLBUTRIN, VRAYLAR, NURTEC ODT, JARDIANCE.
Industry payments across MD — which companies pay providers there.
